[Federal Register Volume 64, Number 98 (Friday, May 21, 1999)] [Notices] [Page 27797] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-12835] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Availability of Draft Guidelines for Prevention of Opportunistic Infections in Persons Infected With Human Immunodeficiency Virus
Agency
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services.
Action
Notice of availability and request for comments.
-----------------------------------------------------------------------
Summary
This notice announces the availability of a draft document entitled ``1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus,'' prepared by representatives of the U.S. Public Health Service (USPHS), the Infectious Diseases Society of America (IDSA), and additional representatives of Federal agencies, universities, professional societies, and community organizations, for review and comment.
Dates
To ensure consideration, written comments on this draft document must be received on or before June 1, 1999.
Addresses
The draft document is available on the World-Wide Web site of the AIDS Treatment and Information Service (www.hivatis.org). Requests for hardcopies of the document may be submitted to the Division of HIV/AIDS Prevention, Mailstop E-49, Centers for Disease Control and Prevention, Atlanta, GA 30333; telephone (404) 639-2072, FAX (404) 639-2007. Written comments on this draft document should be sent to the above address for receipt by June 1, 1999.
www.hivatis.orgFor Further Information Contact
Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Mailstop E-49, Centers for Disease Control and Prevention, Atlanta, GA 30333; telephone (404) 639-2072, FAX (404) 639-2007.
Supplementary Information
Opportunistic infections constitute a major cause of morbidity and mortality in persons infected with human immunodeficiency virus. The draft 1999 Guidelines, prepared by the United States Public Health Services, the Infectious Diseases Society of America, and representatives of Federal agencies, universities, professional societies, and community organizations, represent an update of guidelines published in 1995 and in 1997. They include recommendations to prevent major parasitic, bacterial, mycotic, and viral infections in the era of highly active antiretroviral therapy (HAART). They address prevention of disease by chemoprophylaxis and vaccination and prevention of exposure to opportunistic pathogens. They also address discontinuing chemoprophylaxis against specific pathogens when the CD4+ lymphocyte count has increased in response to HAART.
Dated: May 17, 1999. Joseph R. Carter, Associated Director for Management and Operations, Centers for Disease Control and Prevention (CDC). [FR Doc. 99-12835 Filed 5-20-99; 8:45 am] BILLING CODE 4163-18-P